These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8317610)

  • 41. Immunohistochemical expression of HBME-1, E-cadherin, and CD56 in the differential diagnosis of thyroid nodules.
    Ozolins A; Narbuts Z; Strumfa I; Volanska G; Stepanovs K; Gardovskis J
    Medicina (Kaunas); 2012; 48(10):507-14. PubMed ID: 23324246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histology and aspiration cytology of benign thyroid diseases.
    Fadda G; LiVolsi VA
    Rays; 1999; 24(2):182-96. PubMed ID: 10509125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follicular lesion of undetermined significance in thyroid FNA revisited.
    Walts AE; Mirocha J; Bose S
    Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R
    Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Low galectin-3 capacity to discriminate thyroid lesions].
    De-León-Mazariegos R; Canedo-Patzi M; Pérez-Enríquez B; Candanedo-Gonzalez F; Saqui-Salces M; Gamboa-Domínguez A; Rull-Rodrigo JA
    Rev Invest Clin; 2004; 56(5):623-8. PubMed ID: 15776867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histochemical localization of Statin--a non-proliferation-specific nuclear protein--in nuclei of normal and abnormal human thyroid tissue.
    Mitmaker B; Kyzer S; Gordon PH; Wang E
    Eur J Histochem; 1992; 36(2):123-36. PubMed ID: 1380846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Risk markers of follicular neoplasms in thyroid nodules].
    Monteros Alvi M; Romero NM; Gonorazky S; Galvez V; Galvez M; Virgili E; De Soler GG
    Medicina (B Aires); 2009; 69(5):497-501. PubMed ID: 19897432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fine needle aspiration of thyroid nodules in a general teaching hospital setting performing moderate number of biopsies: outcome of indeterminate cytologic results.
    Bazrafshan H; Azarhoush R; Gholamrezanezhad A
    Endokrynol Pol; 2008; 59(5):385-9. PubMed ID: 18979447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clear cell follicular adenoma of the thyroid.
    Chen KT
    J Surg Oncol; 1987 Mar; 34(3):170-1. PubMed ID: 3821125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue.
    Campo E; Merino MJ; Liotta L; Neumann R; Stetler-Stevenson W
    Hum Pathol; 1992 Dec; 23(12):1395-401. PubMed ID: 1468777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid.
    Johannessen JV; Sobrinho-Simões M; Lindmo T; Tangen KO
    Am J Clin Pathol; 1982 Jan; 77(1):20-5. PubMed ID: 7055095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of S100C in thyroid lesions.
    Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
    Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fine needle aspiration cytologic study of the solitary thyroid nodule. Profile of 308 cases with histologic correlation.
    Jayaram G
    Acta Cytol; 1985; 29(6):967-73. PubMed ID: 3866460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Birefringent crystals in human thyroid.
    MacMahon HE; Lee HY; Rivelis CF
    Acta Endocrinol (Copenh); 1968 May; 58(1):172-6. PubMed ID: 5695047
    [No Abstract]   [Full Text] [Related]  

  • 60. GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
    Haber RS; Weiser KR; Pritsker A; Reder I; Burstein DE
    Thyroid; 1997 Jun; 7(3):363-7. PubMed ID: 9226204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.